Opin vísindi
Therapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine
- Opin vísindi
- →
- IRIS
- →
- IRIS
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor | Landspitali - The National University Hospital of Iceland |
| dc.contributor.author | Møller, Morten H |
| dc.contributor.author | Chew, Michelle S |
| dc.contributor.author | Olkkola, Klaus T |
| dc.contributor.author | Rehn, Marius |
| dc.contributor.author | Yli-Hankala, Arvi |
| dc.contributor.author | Sigurðsson, Martin Ingi |
| dc.date.accessioned | 2022-05-13T01:02:55Z |
| dc.date.available | 2022-05-13T01:02:55Z |
| dc.date.issued | 2022-02-28 |
| dc.identifier.citation | Møller , M H , Chew , M S , Olkkola , K T , Rehn , M , Yli-Hankala , A & Sigurðsson , M I 2022 , ' Therapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine ' , Acta Anaesthesiologica Scandinavica , vol. 66 , no. 5 , pp. 636-637 . https://doi.org/10.1111/aas.14046 |
| dc.identifier.issn | 0001-5172 |
| dc.identifier.other | 48356120 |
| dc.identifier.other | 38a07989-6a8a-4243-acd9-1d96757a7d13 |
| dc.identifier.other | 35170027 |
| dc.identifier.other | unpaywall: 10.1111/aas.14046 |
| dc.identifier.other | 85125900433 |
| dc.identifier.uri | https://hdl.handle.net/20.500.11815/3169 |
| dc.description | Funding Information: Funding was provided from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine and institutional and/or departmental sources. Publisher Copyright: © 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation. |
| dc.description.abstract | The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19. |
| dc.format.extent | 2 |
| dc.format.extent | 366299 |
| dc.format.extent | 636-637 |
| dc.language.iso | en |
| dc.relation.ispartofseries | Acta Anaesthesiologica Scandinavica; 66(5) |
| dc.rights | info:eu-repo/semantics/openAccess |
| dc.subject | Svæfinga- og gjörgæslulæknisfræði |
| dc.subject | Anesthesiology |
| dc.subject | COVID-19 |
| dc.subject | Critical Care |
| dc.subject | Humans |
| dc.subject | Societies, Medical |
| dc.subject | World Health Organization |
| dc.subject | therapeutics |
| dc.subject | AGREE II |
| dc.subject | clinical practice guideline |
| dc.subject | WHO |
| dc.subject | Anesthesiology and Pain Medicine |
| dc.title | Therapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine |
| dc.type | /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article |
| dc.description.version | Peer reviewed |
| dc.identifier.doi | 10.1111/aas.14046 |
| dc.relation.url | http://www.scopus.com/inward/record.url?scp=85125900433&partnerID=8YFLogxK |
| dc.contributor.department | Perioperative Services |
| dc.contributor.department | Faculty of Medicine |
